BACKGROUND: Over the last 50 years left bundle branch block (LBBB) has been defined as homophasic (concordant: cLBBB) or heterophasic (discordant: dLBBB) when associated with a positive or negative T wave in leads I and V5-V6, respectively. LBBB is recognized as an adverse prognostic factor in heart failure (HF). The prevalence and clinical significance of cLBBB and dLBBB in HF patients are unknown. METHODS AND RESULTS: A total of 897 consecutive systolic HF patients (age 65 +/- 13 years, left ventricular ejection fraction [LVEF], 34 +/- 10%) underwent clinical characterization, electrocardiographic evaluation for LBBB diagnosis and classification, and follow-up for cardiac events (median 37 months, range 1-84). LBBB was diagnosed in 232 patients (26%), cLBBB in 71 (31%), and dLBBB in 161 (69%). The dLBBB patients were older than those with cLBBB, and presented with lower LVEF, greater left ventricular telediastolic diameter and left ventricular mass index, higher level of brain natriuretic peptide, N-terminal pro-brain natriuretic peptide, renin activity, and norepinephrine (all P < .05). At Kaplan-Meier analysis, LBBB (P = .003) and dLBBB (P = .036) were associated with a worse prognosis when the composite end point of sudden death and implantable cardioverter defibrillator shock was considered. CONCLUSIONS: In systolic HF, dLBBB is associated with a worse clinical, neurohormonal, and prognostic profile. LBBB classification could represent a useful tool in routine clinical evaluation. (c) 2010 Elsevier Inc. All rights reserved.
BACKGROUND: Over the last 50 years left bundle branch block (LBBB) has been defined as homophasic (concordant: cLBBB) or heterophasic (discordant: dLBBB) when associated with a positive or negative T wave in leads I and V5-V6, respectively. LBBB is recognized as an adverse prognostic factor in heart failure (HF). The prevalence and clinical significance of cLBBB and dLBBB in HF patients are unknown. METHODS AND RESULTS: A total of 897 consecutive systolic HFpatients (age 65 +/- 13 years, left ventricular ejection fraction [LVEF], 34 +/- 10%) underwent clinical characterization, electrocardiographic evaluation for LBBB diagnosis and classification, and follow-up for cardiac events (median 37 months, range 1-84). LBBB was diagnosed in 232 patients (26%), cLBBB in 71 (31%), and dLBBB in 161 (69%). The dLBBB patients were older than those with cLBBB, and presented with lower LVEF, greater left ventricular telediastolic diameter and left ventricular mass index, higher level of brain natriuretic peptide, N-terminal pro-brain natriuretic peptide, renin activity, and norepinephrine (all P < .05). At Kaplan-Meier analysis, LBBB (P = .003) and dLBBB (P = .036) were associated with a worse prognosis when the composite end point of sudden death and implantable cardioverter defibrillator shock was considered. CONCLUSIONS: In systolic HF, dLBBB is associated with a worse clinical, neurohormonal, and prognostic profile. LBBB classification could represent a useful tool in routine clinical evaluation. (c) 2010 Elsevier Inc. All rights reserved.
Authors: Sunil Jit R J Logantha; Xue J Cai; Joseph Yanni; Mark R Boyett; George Hart; Caroline B Jones; Robert S Stephenson; Luke Stuart; Gillian Quigley; Oliver Monfredi; Shu Nakao; Il-Young Oh; Tobias Starborg; Ashraf Kitmitto; Akbar Vohra; Robert C Hutcheon; Antonio F Corno; Jonathan C Jarvis; Halina Dobrzynski Journal: Circ Heart Fail Date: 2021-06-30 Impact factor: 8.790
Authors: Joseph Yanni; Alicia D'Souza; Yanwen Wang; Ning Li; Brian J Hansen; Stanislav O Zakharkin; Matthew Smith; Christina Hayward; Bryan A Whitson; Peter J Mohler; Paul M L Janssen; Leo Zeef; Moinuddin Choudhury; Min Zi; Xue Cai; Sunil Jit R J Logantha; Shu Nakao; Andrew Atkinson; Maria Petkova; Ursula Doris; Jonathan Ariyaratnam; Elizabeth J Cartwright; Sam Griffiths-Jones; George Hart; Vadim V Fedorov; Delvac Oceandy; Halina Dobrzynski; Mark R Boyett Journal: Sci Rep Date: 2020-07-09 Impact factor: 4.379